MODIFIED PROSTAGLANDIN COMPOUNDS AND ANALOGS THEREOF, COMPOSITIONS CONTAINING THE SAME USEFUL FOR THE TEATMENT OF CANCER

Details for Australian Patent Application No. 2002343661 (hide)

Owner UNITED THERAPEUTICS CORPORATION

Inventors SHORR, Robert; ROTHBLATT, Martine; BENTLEY, Michael; ZHAO, Xuan

Pub. Number AU-A-2002343661

PCT Number PCT/US02/36234

PCT Pub. Number WO2003/049676

Priority 10/006,197 10.12.01 US

Filing date 12 November 2002

Wipo publication date 23 June 2003

Event Publications

27 February 2003 Complete Application Filed

  Priority application(s): 10/006,197 10.12.01 US

28 August 2003 Application Open to Public Inspection

  Published as AU-A-2002343661

26 August 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002343662-Aryl aniline beta-2 adrenergic receptor agonists

2002343660-CATHODIC PROTECTION SYSTEM FOR AIR COMPRESSOR TANKS